Clinical Trials Logo

Clinical Trial Summary

Patients who are to benefit from an injection of SYNOVIUM HCS as part of their care will be offered to participate in this study. Patients will need to sign a consent form to participate. Prior to SYNOVIUM HCS injection, patients will be asked a series of questions regarding their pain and disability. Data collected during follow-up visits can be compared to pre-injection data.


Clinical Trial Description

Inclusion period: 6 months Follow-up period: - 6-month follow-up, after intra-articular injection with extension - 1 single syringe of SYNOVIUM HCS (3 mL), - Controls scheduled at 1 week, 1, 3, 6 months and up to 1 year - Additional control (single) in the event of leaving the study if this takes place outside the scheduled visit dates and before 1 year, for medical reasons - Duration of the study: Overall time estimated at 18 months - In this open-label CI, the group itself is used as a control, by comparing the scores on inclusion with those of the various control visits. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06087705
Study type Observational
Source LCA Pharmaceutical
Contact Patrice VINCENT
Phone 02 37 33 39 30
Email pvin@lca-pharma.com
Status Recruiting
Phase
Start date February 7, 2023
Completion date August 1, 2024

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04460989 - Assessment of Patient Satisfaction After Arthroplasty: A Comparative Study by Implant Type
Recruiting NCT02411097 - Role of Femoral Nerve Block on Prevention of Postoperative Deep Venous Thromboembolism N/A
Not yet recruiting NCT05435690 - Evaluation of a New Navigation System in Computer-assisted Total Knee Arthroplasty N/A
Completed NCT06308887 - Comparison of Ultrasound-Guided Perimeniscal Steroid and 5% Dextrose Injections in Knee Osteoarthritis Phase 4
Recruiting NCT03951545 - Clinical and Radiological Impact of Tibial Cutting Int Total Knee Arthroplasty, Accelerated Navigation Versus Extramedullary Targeting N/A
Recruiting NCT06302075 - Functional Recovery After Medial Monocompartmental Knee Prosthesis: One Day Protocol Versus Fast Protocol N/A
Not yet recruiting NCT05877027 - Exercise vs. Topical Diclofenac vs. PRP N/A
Recruiting NCT04424628 - Radiotherapy 3 vs 6 Gy in Gonarthrosis and Coxarthrosis N/A
Completed NCT04577521 - The Safety and Efficacy of Single IA-HA Injection in Patients With Knee Osteoarthritis: A Prospective Study
Recruiting NCT05814471 - Validation orthèse Pour Gonarthrose N/A
Completed NCT01773226 - Evaluation of Intra-articular Injection of Autologous Protein Solution ("APS(TM)") for the Treatment of Osteoarthritis (OA) N/A
Completed NCT02638831 - Ketorol Gel in Gonarthrosis and Low Back Pain Phase 4
Not yet recruiting NCT06314191 - Adipose Tissue and Symptomatic Gonarthrosis N/A
Completed NCT02977936 - Management of Joint Pain Associated With Osteoarthritis of the Knee With Association of Plant Extracts.
Recruiting NCT05062109 - Multimodal Geriatric Pre-authorization Before Scheduled Orthopedic Surgery N/A
Recruiting NCT02251535 - In-vivo Comparison of Different Levels of Femoral Rollback in a Primary Total Knee Arthroplasty N/A
Active, not recruiting NCT03734315 - Routine Application of Ostenil® in Patients With Gonarthrosis
Completed NCT03389607 - The Role of SCUBE-1 in Ischemia-reperfusion Injury
Completed NCT04225182 - Evaluation of the Effectiveness of a Muscular Strengthening Protocol With an Instrumented Orthosis for Gonarthrosis Patients N/A
Recruiting NCT04313894 - WHARTON JELLY ORIGINATED MESENCHIAL STEM CELL in GONARTHROSIS Phase 2